Abstract To determine whether age-dependent differences in cardiac responses to autonomic agonists could result from developmental changes in protein kinase C (PKC) isoform expression, we probed extracts from the fetal, neonatal, and adult heart as well as cultured neonatal and isolated adult ventricular myocytes with specific antisera to calcium-dependent (a and 18) and calcium-independent (8, E, and ;) isoforms of the enzyme. Although PKC-/3 immunoreactivity could not be detected in cultured neonatal or isolated adult ventricular myocytes, adult and neonatal myocytes expressed multiple other isoforms of PKC. Our studies revealed an age-dependent decline in the immunoreactivity for three PKC isoforms. PKC-a was detected in extracts from the fetal and 2-day-old neonatal heart as well as cultured neonatal rat ventricular myocytes. Only faint PKC-a immunoreactivity was detected in extracts from the adult heart, and PKC-a was not detected in extracts from isolated adult ventricular myocytes, suggesting that PKC-a resides in nonmyocyte elements in the adult heart. PKC-8 also was detected in greater abundance in fetal and neonatal than in adult myocardial extracts. The decline in PKC-a and PKC-8 expression occurred during the first 2 postnatal weeks. PKC-4was detected in greatest abundance in extracts from the fetal heart. PKC-; expression declined markedly by the second postnatal day, and only faint PKC-; immunoreactivity was detected in extracts from adult myocardium. Failure to detect PKC-; in extracts from isolated adult ventricular myocytes suggests that PKC-4 resides primarily in T Nhe cardiac response to a variety of autonomic agonists is dependent on the developmental stage of the heart. It is now well established that at least some of these differences result from agedependent changes in components of the membrane receptor complex and/or intracellular nonmyocyte elements in the adult heart. PKC-e was detected in all preparations, but it was detected in greatest abundance in extracts from neonatal hearts. In vitro sympathetic innervation of previously noninnervated neonatal ventricular myocytes or in vivo chemical sympathectomy of the neonatal heart did not modulate PKC isoform expression, suggesting that sympathetic innervation does not significantly regulate PKC isoform expression. PKC-a partitioned to the soluble fraction of unstimulated myocytes and was selectively translocated to the particulate fraction by Ca2`. In contrast, a major portion of the novel PKC isoforms partitioned to the particulate fraction of unstimulated myocytes. The subcellular distribution of novel PKC isoforms was not influenced by Ca`+. 12-O-Tetradecanoylphorbol 13-acetate (TPA, 300 nmol/L) induced translocation of soluble PKC-a, PKC-8, and PKC-E to the particulate fraction at 30 minutes and complete (PKC-a and PKC-8) or 80% (PKC-E) downregulation at 24 hours. PKC-was not affected by TPA. We conclude that multiple PKC isoforms, which differ in their subcellular distribution and regulation by Ca2+ and phorbol esters, are expressed in the heart in an age-dependent fashion. The observation that the developmental decline in PKC-4 precedes the fall in PKC-a and PKC-8 suggests that PKC isoform expression is controlled by distinct mechanisms that are regulated differently during development. (Circ Res. 1994;74:299-309.) Key Words * protein kinase C * development * cardiac myocytes * phorbol esters implicated as a candidate-signaling molecule in receptordependent induction of myocyte hypertrophy.5,6 Although phorbol esters also have been reported to modulate contractile function, the results are inconsistent.7-10 As a result, the precise role of PKC in mediating receptor-dependent regulation of myocardial cell contractility remains controversial.
nonmyocyte elements in the adult heart. PKC-e was detected in all preparations, but it was detected in greatest abundance in extracts from neonatal hearts. In vitro sympathetic innervation of previously noninnervated neonatal ventricular myocytes or in vivo chemical sympathectomy of the neonatal heart did not modulate PKC isoform expression, suggesting that sympathetic innervation does not significantly regulate PKC isoform expression. PKC-a partitioned to the soluble fraction of unstimulated myocytes and was selectively translocated to the particulate fraction by Ca2`. In contrast, a major portion of the novel PKC isoforms partitioned to the particulate fraction of unstimulated myocytes. The subcellular distribution of novel PKC isoforms was not influenced by Ca`+. 12-O-Tetradecanoylphorbol 13-acetate (TPA, 300 nmol/L) induced translocation of soluble PKC-a, PKC-8, and PKC-E to the particulate fraction at 30 minutes and complete (PKC-a and PKC-8) or 80% (PKC-E) downregulation at 24 hours. PKC-was not affected by TPA. We conclude that multiple PKC isoforms, which differ in their subcellular distribution and regulation by Ca2+ and phorbol esters, are expressed in the heart in an age-dependent fashion. The observation that the developmental decline in PKC-4 precedes the fall in PKC-a and suggests that PKC isoform expression is controlled by distinct mechanisms that are regulated differently during development. (Circ Res. 1994; 74:299-309.) Key Words * protein kinase C * development * cardiac myocytes * phorbol esters implicated as a candidate-signaling molecule in receptordependent induction of myocyte hypertrophy. 5, 6 Although phorbol esters also have been reported to modulate contractile function, the results are inconsistent.7-10 As a result, the precise role of PKC in mediating receptor-dependent regulation of myocardial cell contractility remains controversial.
PKC is a family of closely related serine-threonine protein kinases that can be classified into two major categories. The conventional PKC isoforms (a, 131, fI1, and y) are characterized enzymatically by their requirement for calcium, phospholipids, and DAG or phorbol ester for activation. This reflects the presence of four conserved domains. The Cl region is the putative phospholipid-and DAG/phorbol ester-binding domain, the C2 region is the putative calcium-binding domain, and the C3 and C4 regions constitute the kinase domain. 4 The novel PKC isoforms (8, E, g, 71/L, 0, and A) are structurally related to the conventional PKC isoforms. However, they lack the C2 domain and do not require calcium for maximal activation.11-6 PKC-; also differs from other members of the PKC gene family in that it contains only one cysteine-rich zinc fingerlike motif in the Cl domain. As a result, neither calcium nor DAG/phorbol ester activates this PKC isoform; the mechanism by which it is activated in intact cells remains unknown.1718 Distinct PKC isoforms differ in their tissue distribution, cofactor regulation, and susceptibility to phorbol ester-induced proteolysis/downregulation.1"-16,19 These differences have led to speculations that distinct PKC isoforms subserve discrete biologic functions. This hypothesis is supported by some recent experimental data.20 '2' There is a paucity of information regarding PKC isoform expression in rat ventricular myocytes. Although several isoforms of PKC have been detected in adult rat heart,22-25 most studies have been performed on extracts from the intact heart, precluding a distinction between PKC isoform expression in cardiac myocytes and PKC isoform expression in coronary vasculature, nerves, and connective tissue elements in the heart. Information regarding PKC isoform expression in neonatal myocytes is even more meager.2627 Cultured neonatal rat ventricular myocytes have been reported to contain multiple isoforms of PKC. In one study, two of the isoforms were characterized as PKC-a and PKC-3, whereas the precise identity of a third isoform was not established. 27 In view of the uncertainties regarding the identity of the PKC isoforms expressed and their actions in the heart, the goal of the present study was to examine PKC isoform expression and to systematically consider the possibility that PKC isoform expression is regulated during normal cardiac development.
Materials and Methods Preparation of Cardiac Myocytes
Cardiac myocytes were dissociated from the ventricles of 2-day-old Wistar rats by a series of trypsin digestions and were cultured according to a protocol described previously. 28 50 ,g/mL aprotinin, 48 ,ug/mL leupeptin, 5 ,umol/L pepstatin A, 1 mmol/L phenylmethylsulfonyl fluoride, 0.1 mmol/L sodium vanadate, and 50 mmol/L NaF) containing 1% sodium dodecyl sulfate (SDS), and homogenized by sonication. Soluble and particulate protein fractions also were prepared from irradiated neonatal cardiac cultures and isolated adult myocytes. For these studies, cells were transferred to ice-cold homogenization buffer (0.8 mL of homogenization buffer per 4x 106 cultured neonatal rat ventricular myocytes or 2.2x 106 isolated adult ventricular myocytes), lysed by sonication, and centrifuged at 100 00(g for 1 hour. The supernatant was removed (soluble fraction), and the pellet was resuspended in 1 to 2 mL preheated homogenization buffer containing 1% SDS (particulate fraction). In experiments designed to determine whether individual PKC isoforms display calcium-dependent translocation to the particulate fraction, cells were sonicated in homogenization buffer containing 3 mmol/L CaCl2 instead of EGTA. Soluble and particulate fractions were then prepared as described above, except that EGTA was added back to the soluble fraction to achieve a final concentration of 3 mmol/L. For studies on intact cardiac tissues, preheated homogenization buffer containing 1% SDS was added to minced myocardium (12 mL/g tissue). After homogenization with a Polytron, total protein extract was prepared as described above. Protein content in the samples was determined according to a modified Lowry assay.
Immunoblot Analysis
Samples were electrophoresed on an 8% SDS-polyacrylamide gel and transferred to nitrocellulose. Prestained molecular weight markers were electrophoresed in parallel. After an incubation in 5% dry milk, 50 mmol/L Tris, pH 7.5, 200 mmol/L NaCl, and 0.1% Triton X-100 (blocking buffer I) for 1 hour at room temperature to block nonspecific binding, the nitrocellulose was probed with a 1:500 dilution of primary PKC isoform-specific antisera in 3% bovine serum albumin, 50 mmol/L Tris, pH 7.5, 200 mmol/L NaCl, 0.1% Triton X-100, and 0.02% NaN3 overnight at 4°C. Five PKC isoform-specific antisera were used. The antisera were generated against synthetic peptides corresponding to amino acids 313 to 326 for PKC-a, amino acids 313 to 329 for PKC-,B, or unique sequences in the carboxy-terminal variable region of PKC-S, PKC-E, and PKC-4. The anti-PKC-a antiserum was affinitypurified. The anti-PKC-/3 antibody recognizes both the ,B1 and ,/11 isoforms of the enzyme. The nitrocellulose was then washed five times, 5 minutes each, with 50 mmol/L Tris, pH 7.5, 200 mmol/L NaCl, and 2% Nonidet P-40 and incubated in the same buffer containing 5% dry milk (blocking buffer II) for 30 minutes at room temperature. To detect bound primary antibody, blots were incubated for 1 hour at room temperature with 'M'I-labeled goat anti-rabbit IgG F(ab')l fragment at a final dilution of 0.25 gCi/mL in blocking buffer II. The nitrocellulose was washed seven times as described above, dried, and autoradiographed with Kodak XAR film with intensifying screens at -70°C. For autoradiograms in which the densities of the bands linearly increased with loading of increased amounts of protein, the relative abundance of individual proteins identified was quantified by scanning densitometry.
To ensure the specificity of the immunoreactive proteins, Western blots were done in the presence and absence of competing immunizing peptide. Isoform-specific antisera (10 Specific PKC-a immunoreactivity was detected in total protein extracts from the neonatal and the adult heart. However, the amount of PKC-a immunoreactivity in the neonatal preparation was much greater than the amount in the adult preparation. Specific PKC-a immunoreactivity also was detected in total protein extracts from cultured neonatal ventricular myocytes; it was not detected in the isolated adult ventricular myocyte preparation. These results suggest that neonatal myocytes express PKC-a; the small amount of PKC-a immunoreactivity detected in total protein extracts from adult myocardium is likely to represent PKC-a expressed by noncardiac muscle cells in the heart. Indeed, PKC-a immunoreactivity was detected in lysates of cardiac fibroblasts (Fig 1, bottom) . One results not shown). These results further support our conclusion that PKC-a is expressed by neonatal rat ventricular myocytes, whereas PKC-a resides primarily in the nonmyocyte elements of the adult ventricle.
Neonatal and adult rat myocardial preparations also were probed with antiserum raised against PKC-,3. This antiserum detected immunoreactivity in total protein extracts from the neonatal and adult heart but failed to detect specific proteins in either of the pure cardiac cellular preparations tested. This antiserum also specifically recognized high levels of a 78-kD protein in lysates of rat 6 embryo fibroblasts, which stably overproduce the /31 form of PKC (Fig 1, top , far right panel).32 It should be noted that PKC-/3 has been detected in extracts from cultured neonatal ventricular myocytes when PKC is partially purified by DEAE cellulose chromatography.26 '27 Thus, it is possible that rat ventricular myocytes express low levels of PKC-/3 that are beneath the limits of detection in this assay. Nevertheless, our results argue that PKC-a is the major calcium-dependent PKC species expressed in neonatal rat ventricular myocardial tissue.
Three novel PKC isoforms were detected in rat myocardium. These novel PKC isoforms were detected both in ventricular myocytes and fibroblasts cultured from the neonatal heart (Fig 1) . Antiserum to PKC-8 detected a single 73-kD species in total protein extracts from the neonatal and adult heart as well as lysates from cultured neonatal and isolated adult cardiomyocytes. However, we noted a striking difference in the abundance of PKC-6 in these preparations. PKC-8 is a major PKC isoform in neonatal myocardium or cultured neonatal ventricular myocytes. In contrast, considerably weaker immunoreactivity was detected in total protein extracts from adult myocardium or isolated adult cardiomyocytes (note that to optimally detect specific immunoreactivity, immunoblots for neonatal and adult tissues were exposed for 23 and 48 hours, respectively).
Immunoblots with antiserum to PKC-E revealed a prominent protein band, which migrated with an apparent molecular mass of -96 kD on SDS-polyacrylamide gel electrophoresis (PAGE), in all neonatal and adult preparations studied. PKC-e was resolved as a protein doublet in some, but not all, experiments (see Fig 5, top, for better resolution of the doublet). The mobility of this protein is similar to the reported molecular mass of PKC-E chromatographically purified from brain. '3,35 In addition to this major higher molecular weight species, a minor 76-kD protein that cross-reacted with the PKC-e-specific antibody was consistently detected in cultured neonatal ventricular myocytes but not in isolated adult cardiomyocytes or in preparations from the intact ventricle. It also was not detected in myocytes freshly isolated from the neonatal ventricle (data not shown). This 76-kD protein appears to represent a PKC-e-like polypeptide, since it was not detected when antiserum was preincubated with peptide antigen. It is not likely to be an artifact due to proteolysis of PKC-E during sample preparation, since it was detected when cultured neonatal myocytes were directly lysed in hot SDS-containing buffer.
Finally, PKC-4was detected as a protein doublet with an apparent molecular mass of -78 kD. Although the predicted molecular mass of PKC-4 is 67 kD,36 higher molecular weight PKC-; species have been detected in several other studies.17'18,23 PKC-Twas easily detected in total protein extracts from the neonatal heart and cultured neonatal cardiomyocyte. Faint PKC-4immuno-reactivity also was observed in total protein extracts from the adult heart but not from isolated adult yentricular cardiomyocytes. The observation that cardiac _-*91W Finally, the effect of calcium and TPA on the subeellular distribution of the two isoforms of PKC expressed in isolated adult cardiomyocytes was determined (Fig  4) . The subcellular distribution of PKC-8 and PKC-E was similar when cell lysis was performed either in EGTA-containing buffers or in the presence of excess calcium. In contrast, both isoforms were recruited to the particulate fraction after exposure to 300 nmol/L TPA for 30 minutes.
Developmental Changes in PKC Isoform Expression
The contractile function of the heart changes substantially during postnatal cardiac development in association with changes in the expression of contractile proteins as well as components of receptor signaling complexes. We probed whole-protein extracts from 14-day-old fetal, 2-to 15-day-old neonatal, and adult hearts with antibodies directed against the a, 8, E, and isoforms of PKC to determine whether the time course for the developmental changes in PKC isoform expression in rat myocardium coincides with these other events. A representative autoradiogram is illustrated in Fig 5, top , and data for 14-day-old fetal, 2-day-old neonatal, and adult preparations are quantified in Fig 5, bottom.
Specific PKC-a immunoreactivity in the 14-day-old fetal and 2-day-old neonatal heart is similar and more than three times greater than the level detected in the adult heart. Similarly, PKC-8 expression is equivalent in extracts from 14- the 2-day-old neonatal heart). For both the a and isoforms of PKC, the decline in immunodetectable protein occurs during the first 2 weeks of postnatal life. As previously established in Fig 1, PKC-6 is expressed at low levels in adult ventricular myocytes, whereas the faint PKC-a immunoreactivity detected in whole-protein extracts from the adult heart is presumed to represent PKC-a in noneardiac cellular elements.
The time course for the developmental decline in PKC-4 expression is quite different. PKC-4 is most abundant in 14-day-old fetal myocardium. PKC-4 expression in 2-day-old neonatal myocardial tissue is only 32% of the level detected in the fetal sample. In extracts from the adult ventricle, PKC-4 expression is reduced to a level that is only 9% of that detected in the fetal sample. This low level of PKC-expression in extracts from the intact adult ventricle is likely to be attributable to PKC-; in contaminating noncardiac cellular elements (see Fig 1) . The observation that PKC-4 is expressed at high levels in fetal myocardium and diminishes rapidly around the time of birth is of considerable interest.
First, the decrease in PKC-4 precedes the decrease in PKC-a and PKC-8, suggesting that the expression of these proteins is controlled by distinct mechanisms that are regulated differently during development. Second, it is particularly intriguing that immature cardiac tissue that retains the capacity for proliferative growth is enriched in PKC-4. It remains to be determined whether the presence of this unique phorbol ester/ DAG-insensitive member of the PKC family in the growing fetal heart is indicative of a specific role for PKC-4 in the signal transduction pathway leading to myocyte proliferation or is simply happenstance.
Finally, we noted modest age-dependent differences in PKC-e expression. Compared with the level of expression in extracts from the 2-day-old neonatal ventricle, immunoreactive PKC-e was reduced by 30% in extracts from the 14-day-old fetal ventricle and 46% in extracts from the adult ventricle. In addition, we noted an age-dependent difference in PKC-E mobility in SDS-PAGE. PKC-e appeared as a doublet in all postnatal samples studied but migrated as the single higher molecular weight immunoreactive species in total protein extracts from the fetal heart. This higher molecular weight PKC-e species in the fetal heart may represent a fully phosphorylated form of the enzyme, which has been reported to be more resistant to degradation and exhibit higher kinase activity than lower molecular weight PKC-e species. 35 These studies do not provide precise quantification of the amounts of distinct PKC isoforms expressed by myocardial tissue. Such information can only be obtained by quantitative immunoblot analysis to correct for any potential differences in titer and/or hybridization efficiency between individual antisera. However, Fig 5 emphasizes that, under identical experimental exceeds that detected for other PKC isoforms in the adult ventricle. These results agree with recent evidence from another laboratory that PKC-e is the most abundantly expressed PKC isoform in the adult rat heart.24 Developmental Changes in PKC Isoform Expression Are Not Dependent on Sympathetic Innervation of the Heart Several laboratories have recently presented compelling evidence that sympathetic innervation of the heart plays an important role in the developmental maturation of certain aspects of myocardial cell function. For example, studies in our laboratory established that developmental changes in a1-adrenergic receptor responsiveness are induced by sympathetic innervation.237 In vitro sympathetic innervation of previously noninnervated neonatal rat ventricular myocytes also has been shown to increase the expression of functional L-type calcium channels,38 alter the gating of the voltage-gated sodium channel,39 and modulate contractile function. 40 Since the age-dependent decline in PKC-a and PKC-8 expression coincides with the onset of sympathetic innervation of the heart, we tested the hypothesis that sympathetic innervation regulates PKC isoform expression. Two experimental paradigms were used. First, we assessed PKC isoform expression in neonatal ventricular myocytes cultured alone or cocultured with and innervated by sympathetic neurons.2 Fig  6 illustrates that in vitro sympathetic innervation of previously noninnervated neonatal ventricular myocytes does not appreciably alter PKC isoform expression, even if the cultured interval is prolonged to 15 days. These results further emphasize the finding that the repression of PKC-ca and PKC-8 isoform expression observed in vivo by postnatal day 15 is lost when ventricular myocytes are maintained in culture for an identical time interval. Second, we altered sympathetic neural development in vivo by repeatedly injecting animals with 6-hydroxydopamine according to a treatment regimen that achieves a high degree of chemical sympatheetomy. 41 We detected comparable levels of each isoform of PKC in total protein extracts from myocardium of 11-day-old vehicle-injected and 11-dayold 6-hydroxydopamine-denervated animals (data not shown). These results further support the conclusion that sympathetic innervation is not the dominant influence regulating the developmental changes in PKC isoform expression in the heart.
Discussion
The goal of the present study was to examine the pattern of PKC isoform expression in the context of cardiac development. Our data indicate that fetal, neonatal, and adult rat ventricular myocytes express multiple isoforms of PKC. Moreover, we demonstrate that development is associated with dramatic changes in calcium-dependent and calcium-independent PKC isoforms expression. The present study begins to clarify some of the discrepancies that have arisen from a literature that characterizes PKC isoforms in the heart without regard for possible age-dependent or cell-specific expression. For example, PKC-a was detected in Although PKC-a also was stimulatory, its effect was substantially more modest than that associated with PKC-f3.21 Given our observation that the major calcium-dependent isoform of PKC in neonatal cardiac myocytes is PKC-a and not PKC-f, the physiological implications of these observed differences in PKC-dependent regulation of gene transcription are uncertain. Nevertheless, evidence that PKC actions in cardiac myocytes are isoform specific supports the notion that the age-dependent differences in PKC isoform expression identified in the present study are likely to be associated with important alterations in biologic responses.
The copresence of at least four different isoforms of PKC in the neonatal heart and two different isoforms of PKC in the adult heart might be expected to impart a high degree of specificity and flexibility to the signaltransduction mechanism. Although a recent study reports a similar translocation of PKC-E from the soluble to the particulate fraction of adult rat ventricular myocytes by two agonists that activate phosphoinositide hydrolysis (epinephrine and endothelin-1),24 it is possible that different PKC isoforms could be activated selectively by different receptor agonists. For example, in neonatal myocytes, calcium, and by implication agonists that increase intracellular calcium ion concentration, selectively translocates PKC-a, but not PKC-8, or PKC-E, from the soluble to the particulate fraction. In contrast, the calcium-insensitive isoforms, which are detected in greater abundance in the neonatal heart and are the only isoforms of PKC detected in the adult heart, might be expected to assume greater importance under conditions in which DAG is formed in the absence of calcium. Such a mechanism could involve receptor-activated phosphatidylcholine hydrolysis, which is stimulated by many agonists that promote phosphoinositide hydrolysis and results in the selective and sustained accumulation of DAG without the calcium-mobilizing second messenger 1P3.45 Moreover, because phosphoinositides and phosphatidylcholine characteristically have different fatty acyl moieties, phosphatidylcholine hydrolysis would be predicted to lead to the production of a distinct pool of DAG, which might differentially activate different isoforms of PKC. At present, the evidence that agonists stimulate the hydrolysis of phosphatidylcholine in cardiac tissue is indirect, and the relative importance of phosphatidylcholine as a source for DAG in the heart is uncertain.46
However, at least theoretically, such a mechanism might be particularly advantageous in cardiac tissue, where elevations in intracellular calcium accompany normal contractile activity.
The multiple isoforms of PKC expressed in the heart are predicted to phosphorylate distinct sets of intracellular target proteins, thereby conferring an additional dimension of complexity to this signal-transduction pathway. PKC isoforms are known to differ intrinsically in their substrate specificity. In addition, consistent with the known effects of activated PKC to phosphorylate proteins throughout the cell, recent studies indicate that distinct PKC isoforms translocate to different intracellular sites on exposure to phorbol esters. These sites include the plasma membrane as well as the cytoskeleton47 and the nuclear envelope.48 PKC isoform-specific translocation to distinct intracellular structures could lead to differences in substrate accessibility and thereby lead to PKC isoformspecific actions. Evidence that such a phenomenon is operative in cultured neonatal rat ventricular myocytes has been presented. An isoform putatively identified as PKC-f3 has been reported to translocate to the sarcolemma and perinuclear area on exposure to phorbol esters, whereas a different, and as yet unidentified, PKC isoform translocates to the myofibrils under the same experimental conditions.27 More recently, Mochly-Rosen and colleagues49'50 identified receptors for activated C kinase (RACKs) in the cytoskeletal-rich fraction of neonatal rat hearts49 and presented evidence that a proteinprotein interaction between PKC and RACKs is a requirement for PKC translocation and PKC-mediated cell activation.50 Taken together, these studies raise the possibility that, on activation, distinct isoforms of PKC translocate to the distinct intracellular sites of their protein substrates and that isoform-dependent differences in substrate specificity as well as isoform-dependent differences in intracellular compartmentalization might determine functional responsiveness. In 
